Status | Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
---|---|---|---|---|---|
Active | CoCoNut | NCT01821456 |
Cologne Cohort of Neutropenic Patients
Purpose / Objectives
Primary Outcome
Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).
Secondary Outcomes
Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).
Diagnosis
- Infectious diseases in Hematology and Oncology
- Infectious diseases: Others
- Maligne Tumorerkrankung (English name missing)
Neutropenia
Target population
Inclusion criteria
All patients neutropenic for at least two consecutive days.
Exclusion criteria
none
Study design
- Single center
- Prospective
Documents (password protected)
Networks
Responsibilities in overall study
Sponsor
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Sponsor representative
Univ.-Prof. Dr. med. Oliver A. Cornely
- Tel. +49 221 478-85523
- Fax +49 221 478-1421445
- oliver.cornely@uk-koeln.de
Univ.-Prof. Dr. med. Jörg Janne Vehreschild
- Tel. +49 (0)221 478-88794 / +49 171 6211442
- Fax +49 (0)221 478-85504
- janne.vehreschild@uni-koeln.de
(National) Coordinating Investigator
Univ.-Prof. Dr. med. Jörg Janne Vehreschild
Project management
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Dr. Sebastian Wingen-Heimann
Data management
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Dr. Sebastian Wingen-Heimann
Database development
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Univ.-Prof. Dr. med. Jörg Janne Vehreschild